Expert faculty will cover a wide range of topics including the diagnosis, management, and state-of-the-art treatment for hypertrophic cardiomyopathy, chemo-induced cardiomyopathy, cardiac amyloidosis, cardiac sarcoidosis, arrhythmias related to each of these diseases, genetic abnormalities that can lead to these diseases, and advanced cardiac imaging.
Hilton San Diego Resort
1775 E Mission Bay Drive
San Diego, California 92109
Significant advances in the diagnosis and management of cardiomyopathies and resultant heart failure continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these cardiovascular conditions. Expert faculty will cover a wide range of topics including the diagnosis, management, and state-of-the-art treatment for hypertrophic cardiomyopathy, chemo-induced cardiomyopathy, cardiac amyloidosis, cardiac sarcoidosis, arrhythmias related to each of these diseases, genetic abnormalities that can lead to these diseases, and advanced cardiac imaging. Faculty will also cover a variety of co-morbid and chronic conditions patients with heart disease may face. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.
After attending this live activity, participants should be able to:
- Incorporate current and emerging clinical evidence in the assessment, treatment and management of patients with challenging cardiovascular disease.
- Integrate new concepts in the imaging of patients with cardiomyopathies.
- Assess new medical and surgical therapies for hypertrophic cardiomyopathy.
- Discuss current pharmacologic strategies for patients with cardiac amyloidosis.
- Employ screening strategies for patients undergoing chemotherapy to help identify cardiac toxicity.
- Describe current pharmacologic and medical management strategies for patients with chemo-induced cardiomyopathy.
- Evaluate device based therapies for heart rhythm disorders related to cardiomyopathies.
- Define current recommendations for the use of genetic testing in the setting of cardiomyopathies.
- Interpret complex case-based imaging of patients with cardiomyopathies.
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Scripps Health designates this educational activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This course is supported, in part, by educational grants from industry, in accordance with ACCME Accreditation Standards for Commercial Support. Appropriate acknowledgement will be given to all supporters at the time of the educational activity.
Cultural and Linguistic Competency
This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area. A variety of resources are available that address cultural and linguistic competency, some of which can be found in the Cultural & Linguistic Competency Resource Guide.
|Sat, Sep 22nd, 2018 - Sat, Sep 22nd, 2018||7:00 a.m. - 3:00 p.m.|